Health & Wellness
Thursday, June 4, 2026 · Incline Village
Gleevec Marked a Turning Point in Cancer Treatment 23 Years Ago
The Food and Drug Administration (FDA) approved Gleevec for leukemia treatment in 2001, marking a new phase in cancer care. The drug offered a targeted treatment, improving survival rates and quality of life for patients.
Gleevec Marked a Turning Point in Cancer Treatment 23 Years Ago
The Food and Drug Administration (FDA) approved Gleevec for leukemia treatment in 2001, marking a new phase in cancer care. The drug offered a targeted treatment, improving survival rates and quality of life for patients.
Thursday, June 4, 2026
Cardiac screening studies find heart conditions in young women at rates comparable to men
Medical researchers have identified cardiac conditions in young women at frequencies similar to those found in young men, according to screening studies. The findings suggest current diagnostic protocols may miss significant numbers of at-risk women.
Thursday, June 4, 2026
Experimental pancreatic cancer pill extends survival in advanced cases
Researchers reported Sunday that an experimental pill helped patients with advanced pancreatic cancer survive longer than current treatments allow. The findings offer a potential new option for a disease that kills most patients within months of diagnosis.
Thursday, June 4, 2026
Federal Judge to Review $1.8 Billion Compensation Fund for Trump Administration
A federal judge has agreed to review a $1.8 billion fund established by the Trump administration to compensate individuals it says suffered wrongful treatment by the federal government. The fund's announcement sparked opposition across Republican and Democratic ranks.
Thursday, June 4, 2026
Experimental Pancreatic Cancer Pill Extends Survival in Clinical Trial
Researchers reported Sunday that an experimental pill extended survival for people with advanced pancreatic cancer, marking a potential advance against one of the most lethal malignancies.
Thursday, June 4, 2026
Study shows pancreatic cancer drug doubles survival for majority of patients
A new study found that daraxonrasib doubled survival rates for more than 90 percent of pancreatic cancer patients. Researchers now plan to test the drug against lung, ovarian, and colorectal cancers.
Thursday, June 4, 2026
U.S. Commits $162 Million to Ebola Response in Congo and Uganda
The United States has committed $162 million to combat an Ebola outbreak in the Democratic Republic of the Congo and Uganda, making it the largest financial contributor to the response effort. The State Department coordinated with Canada and Mexico on travel screening measures ahead of the 2026 FIFA World Cup.
Thursday, June 4, 2026
Overdose cases linked to GLP-1 weight loss drugs prompt scrutiny
NBC News correspondent Anne Thompson reported findings from an investigation into overdose cases associated with GLP-1 drugs used for weight loss. The report, conducted in partnership with KFF Health News, documents a rise in such incidents.
Thursday, June 4, 2026
Injectable Immunotherapy Offers Faster Cancer Treatment Option
A new injectable form of immunotherapy could significantly decrease treatment time for thousands of cancer patients. The new method reduces administration time from hours to minutes.
Thursday, June 4, 2026
Hantavirus Suspected in Cruise Ship Deaths
Three people aboard a cruise ship in the Atlantic Ocean died after a suspected hantavirus outbreak. Health organizations are investigating the incident, which also left others sickened.
Thursday, June 4, 2026
Hantavirus Outbreak on Cruise Ship Kills Three, WHO Reports
The World Health Organization reported three deaths linked to a hantavirus outbreak on a cruise ship in the Atlantic Ocean. Hantaviruses spread through contact with infected rodents. The infections, while rare, can cause severe respiratory illness.
Thursday, June 4, 2026
FDA Releases Results of Infant Formula Contaminant Testing
The Food and Drug Administration published findings from its most extensive analysis of chemical contaminants in infant formula sold in the United States. The study examined a range of products available to consumers. The agency plans to use the data to inform future regulatory decisions.
Thursday, June 4, 2026
CDC to Brief Public on Swine Influenza Investigation
The Centers for Disease Control and Prevention will hold a briefing to update the public on its investigation into human cases of swine influenza. The briefing is scheduled for Thursday, April 30, 2009, at 11:30 a.m. ET.
Thursday, June 4, 2026
U.S. Infant Mortality Rate Declines in Global Ranking
A recent Centers for Disease Control and Prevention report indicated a decline in the United States' global ranking for infant mortality rates. The data compared U.S. rates against those of other nations across several decades. The report tracked changes in the U.S. global position.
Thursday, June 4, 2026
Obesity, Diabetes Rates Highest in Parts of South, Appalachia, and Tribal Lands, CDC Estimates
The Centers for Disease Control and Prevention released estimates showing higher rates of obesity and diabetes in specific regions. These include the Southeast, Appalachia, and some tribal lands in the West and Northern Plains. The data underscores geographic health disparities.
Thursday, June 4, 2026
Study Links Maternal Obesity to Increased Risk of Infant Heart Defects
A recent study in the United States suggests a correlation between a mother's pre-pregnancy weight and the likelihood of her child developing certain heart defects. Researchers found an increased risk among women classified as overweight or obese before conceiving.
Thursday, June 4, 2026
CDC Updates H1N1 Vaccine Recommendations
The Centers for Disease Control and Prevention (CDC) held a press conference to announce updated recommendations regarding the use of the novel influenza A (H1N1) vaccine. The Advisory Committee on Immunization Practices (ACIP) provided the insights leading to the new guidance. Details on specific populations and dosage are expected.
Thursday, June 4, 2026
CDC Investigates Human H1N1 Flu Cases
The Centers for Disease Control and Prevention (CDC) is investigating recent human cases of the H1N1 influenza virus. Health authorities are working to understand the virus's characteristics and spread. The CDC is urging the public to take preventative measures.
Thursday, June 4, 2026
CDC to Provide Update on Novel H1N1 Influenza Cases
The Centers for Disease Control and Prevention (CDC) will hold a telephone briefing to discuss the ongoing investigation into cases of novel influenza A (H1N1). The briefing will address a new report focused on H1N1 infections among healthcare personnel.
Thursday, June 4, 2026
CDC Advisory Panel Issues H1N1 Vaccine Recommendations
Advisors to the Centers for Disease Control and Prevention met to formulate guidelines for distributing the novel H1N1 influenza vaccine. Initial recommendations focus on vaccinating specific populations due to an anticipated scarcity of doses.
Thursday, June 4, 2026
Obesity Costs U.S. Healthcare System Up to $147 Billion Annually, Study Finds
A new study estimates the annual medical costs associated with obesity in the United States may reach $147 billion. The Centers for Disease Control and Prevention partnered with the Research Triangle Institute to develop the estimate. The study highlights the significant economic impact of obesity on the nation's healthcare system.
Thursday, June 4, 2026
Adult Obesity Rate Rises in United States
The percentage of obese adults in the U.S. increased in 2008, according to new data. The U.S. Centers for Disease Control and Prevention tracked a rise from 25.6% to 26.1%.
Thursday, June 4, 2026
CDC Hosts First 'Weight of the Nation' Conference on Obesity Prevention
The Centers for Disease Control and Prevention convened its inaugural 'Weight of the Nation' conference. Participants are discussing policy and environmental strategies to prevent and control obesity.
Thursday, June 4, 2026
Study Links H1N1 Flu to Higher Hospitalization and Mortality Rates in Pregnant Women
A study published in *The Lancet* medical journal found pregnant women infected with the 2009 H1N1 virus experienced higher hospitalization and death rates compared to the general population. Researchers highlight the need for prompt antiviral treatment.
Thursday, June 4, 2026
CDC Investigates Human Cases of H1N1 Influenza A
The Centers for Disease Control and Prevention is investigating human cases of a novel Influenza A (H1N1) strain. The agency will hold a briefing to discuss findings. Health officials are closely monitoring the situation.
Thursday, June 4, 2026
CDC Study Finds Higher Levels of Carcinogens in Some U.S. Cigarette Brands
A new CDC study reveals that certain cigarette brands sold in the United States contain higher levels of tobacco-specific nitrosamines (TSNAs), major cancer-causing agents, compared to some foreign brands. The research highlights variations in carcinogen exposure based on cigarette source.
Thursday, June 4, 2026
CDC Report Shows Binge Drinking Common Among Young People
A new report from the Centers for Disease Control and Prevention indicates that binge drinking is prevalent among high school students and young adults. The CDC's findings show over a quarter of individuals between 18 and 34 years old reported the behavior.
Thursday, June 4, 2026
CDC Survey Indicates Prescription Drug Abuse Among High School Students
A Centers for Disease Control and Prevention survey found that a significant portion of U.S. high school students are misusing prescription drugs. The 2009 National Youth Risk Behavior Survey (YRBS) highlighted the issue.
Thursday, June 4, 2026
Diabetes Prevalence in U.S. Could Triple by 2050, CDC Analysis Shows
A new analysis from the Centers for Disease Control and Prevention projects that up to one in three U.S. adults could have diabetes by 2050. The projection raises concerns about public health and resource allocation.
Thursday, June 4, 2026